Bad Blood

by John Carreyrou

Book Reviews

  • I'm currently reading Bad Blood by John Carreyrou and WOW. It is so worth the read. It's like watching a trainwreck unfold in front of you as a bystander, wishing you could just tell someone, anyone, that none of this is a good idea.Link to Tweet
  • 35. Bad Blood: Secrets and Lies in a Silicon Valley Startup by John Carreyrou. 🌶️🌶️🌶️🌶️ https://t.co/OrNQiCcLClLink to Tweet
  • 33. Super Pumped: The Battle for Uber by Mike Isaac. I unapologetically enjoyed this highly theatrical book. The book is written in an interesting way, the third person storytelling narration + pure chaos within Uber didn't make any of it feel real. I...need to read Bad Blood.Link to Tweet
  • Finally read Bad Blood, and it is difficult not to see David Boies as the linchpin figure in the Theranos story who made all the “trade” secrecy plausible and the bad stories go away for so long https://t.co/Bfl8hGTb8ELink to Tweet
  • Last year I recommended “Bad Blood,” which is about the rise and fall of Theranos. This year I’m recommending “Nine Pints,” another book about blood that you won’t want to put down. https://t.co/AcnsyCT9TRLink to Tweet
  • Just finished Bad Blood by @JohnCarreyrou - felt so close to the story as I (1) shared floor w/ someone @Google a whole chapter was dedicated to (2) had xchanged emails w/ Sunny asking to meet (he declined) & (3) had strongly recommended theranos to a friend who almost joined! 😲 https://t.co/rqR34HZP7ZLink to Tweet
  • @susanthesquark Fiction: the name of the wind, Lexicon, Autonomous, All the light we cannot see. Nonfiction: Bad Blood, Pandora’s labLink to Tweet
  • Best new reads: "Bad Blood" and "Educated" were great. (But you knew that from skimming best of 2018 lists, right?)Link to Tweet
  • I finished reading Bad Blood this weekend. The most stunning part of Theranos was the lack of technical diligence by investors & advisors who enabled this behavior. I often see the same lack of diligence with crypto investors and it’s a troubling sign. We need to do better.Link to Tweet
  • Me yesterday: Pusha T vs. Drake makes tech feuds like Snapchat vs Facebook seem like playground spats. Me today, reading the Theranos book (https://t.co/Trhr9w1c7f): https://t.co/GvP84fuQseLink to Tweet

About Book

The Financial Times & McKinsey Business Book of the Year A New York Times Notable Book A Washington Post Notable Book One of the Best Books of the Year: NPR, San Francisco Chronicle, Time, Esquire, Fortune, Marie Claire, GQ, Mental Floss, Science Friday, Bloomberg, Popular Mechanics, BookRiot, The Seattle Times, The Oregonian, Publishers Weekly, Library Journal In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.5 billion. There was just one problem: The technology didn't work. Erroneous results put patients in danger, leading to misdiagnoses and unnecessary treatments. All the while, Holmes and her partner, Sunny Balwani, worked to silence anyone who voiced misgivings--from journalists to their own employees. Rigorously reported and fearlessly written, Bad Blood is a gripping story of the biggest corporate fraud since Enron--a tale of ambition and hubris set amid the bold promises of Silicon Valley.